Lipidil Supra Interactions
There are 143 drugs known to interact with Lipidil Supra (fenofibrate), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 21 are major, 120 are moderate, and 2 are minor.
- View all 143 medications that may interact with Lipidil Supra
- View Lipidil Supra alcohol/food interactions (1)
- View Lipidil Supra disease interactions (6)
Most frequently checked interactions
View interaction reports for Lipidil Supra (fenofibrate) and the medicines listed below.
- Actos (pioglitazone)
- allopurinol
- apixaban
- Aspir 81 (aspirin)
- aspirin
- Aspirin Low Strength (aspirin)
- atenolol
- atorvastatin
- bisoprolol
- candesartan
- Crestor (rosuvastatin)
- diazepam
- escitalopram
- ezetimibe
- ferrous gluconate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- fluoxetine
- furosemide
- Gaviscon Extra Relief Formula (alginic acid / aluminum hydroxide / magnesium carbonate)
- hydrochlorothiazide
- Janumet (metformin / sitagliptin)
- Lipitor (atorvastatin)
- magnesium oxide
- metformin
- metoprolol
- Micardis (telmisartan)
- pantoprazole
- Plavix (clopidogrel)
- rosuvastatin
- Vitamin D3 (cholecalciferol)
Lipidil Supra alcohol/food interactions
There is 1 alcohol/food interaction with Lipidil Supra (fenofibrate).
Lipidil Supra disease interactions
There are 6 disease interactions with Lipidil Supra (fenofibrate) which include:
- biliary cirrhosis
- cholelithiasis
- liver disease
- renal dysfunction
- rhabdomyolysis
- hematological changes
More about Lipidil Supra (fenofibrate)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: fibric acid derivatives
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.